{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:19:56Z","timestamp":1784895596186,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ogc.2021.02.007","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T23:01:39Z","timestamp":1620428499000},"page":"371-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Evaluation and Management of Suspected Fetal Growth Restriction"],"prefix":"10.1016","volume":"48","author":[{"given":"Claartje","family":"Bruin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Damhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Gordijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wessel","family":"Ganzevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ogc.2021.02.007_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12884-017-1513-3","article-title":"Multidisciplinary consensus on screening for, diagnosis and management of fetal growth restriction in the Netherlands","volume":"17","author":"Verfaille","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"10.1016\/j.ogc.2021.02.007_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2021.02.007_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pedneo.2013.05.005","article-title":"Parental smoking during pregnancy and its association with low birth weight, small for gestational age, and preterm birth offspring: a birth cohort study","volume":"55","author":"Ko","year":"2014","journal-title":"Pediatr Neonatol"},{"issue":"38","key":"10.1016\/j.ogc.2021.02.007_bib4","doi-asserted-by":"crossref","first-page":"15212","DOI":"10.1073\/pnas.1205282109","article-title":"Metabolic hypothesis for human altriciality","volume":"109","author":"Dunsworth","year":"2012","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"1","key":"10.1016\/j.ogc.2021.02.007_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/uog.19110","article-title":"Ultrasound fetal weight estimation at term may do more harm than good","volume":"52","author":"Thilaganathan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ogc.2021.02.007_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nri1514","article-title":"A\u00a0bad combination","volume":"4","author":"Bell","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.ogc.2021.02.007_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jsgi.2004.03.003","article-title":"Placental oxidative stress: from miscarriage to preeclampsia","volume":"11","author":"Burton","year":"2004","journal-title":"J\u00a0Soc Gynecol Investig"},{"issue":"7","key":"10.1016\/j.ogc.2021.02.007_bib8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"2S","key":"10.1016\/j.ogc.2021.02.007_bib9","doi-asserted-by":"crossref","first-page":"S803","DOI":"10.1016\/j.ajog.2017.11.575","article-title":"A\u00a0placenta clinic approach to the diagnosis and management of fetal growth restriction","volume":"218","author":"Kingdom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ogc.2021.02.007_bib10","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1016\/j.ajpath.2015.06.020","article-title":"Increased apoptosis, altered oxygen signaling, and antioxidant defenses in first-trimester pregnancies with high-resistance uterine artery blood flow","volume":"185","author":"Leslie","year":"2015","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.ogc.2021.02.007_bib11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.0960-7692.2001.00591.x","article-title":"The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens","volume":"18","author":"Baschat","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2021.02.007_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.0960-7692.2001.00590.x","article-title":"Monitoring of fetuses with intrauterine growth restriction: a longitudinal study","volume":"18","author":"Hecher","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2021.02.007_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/uog.18809","article-title":"Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcomes: a systematic review and meta-analysis","volume":"51","author":"Schreurs","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2021.02.007_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02441484","article-title":"Mathematical model for interpretation of Doppler velocity waveform indices","volume":"27","author":"Thompson","year":"1989","journal-title":"Med Biol Eng Comput"},{"issue":"2","key":"10.1016\/j.ogc.2021.02.007_bib15","first-page":"53","article-title":"Case-control study of factors associated with intrauterine fetal deaths","volume":"6","author":"Efkarpidis","year":"2004","journal-title":"MedGenMed"},{"issue":"3","key":"10.1016\/j.ogc.2021.02.007_bib16","doi-asserted-by":"crossref","first-page":"288.e1-5","DOI":"10.1016\/j.ajog.2014.05.008","article-title":"The role of brain sparing in the prediction of adverse outcomes in intrauterine growth restriction: results of the multicenter PORTO Study","volume":"211","author":"Flood","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.ogc.2021.02.007_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.AOG.0000253215.79121.75","article-title":"Predictors of neonatal outcome in early-onset placental dysfunction","volume":"109","author":"Baschat","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"19","key":"10.1016\/j.ogc.2021.02.007_bib18","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ogc.2021.02.007_bib19","doi-asserted-by":"crossref","first-page":"163.e1-7","DOI":"10.1016\/j.ajog.2011.09.019","article-title":"Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?","volume":"206","author":"Benton","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2021.02.007_bib20","first-page":"211A","article-title":"Placental growth factor (PLGF) maternal circulating levels in normal pregnancies and in pregnancies at risk of developing placental insufficiency complications","volume":"19","author":"Calabrese","year":"2012","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ogc.2021.02.007_bib21","first-page":"121","article-title":"Placental growth factor (PLGF) and ultrasound parameters for predicting the small for gestational age infant (SGA) in suspected small for gestational age: Pelican FGR study","volume":"27","author":"Griffin","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.ogc.2021.02.007_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0378-3782(89)90076-5","article-title":"Behavioural state transitions in healthy and growth retarded fetuses","volume":"19","author":"Arduini","year":"1989","journal-title":"Early Hum Dev"},{"issue":"4","key":"10.1016\/j.ogc.2021.02.007_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"issue":"3","key":"10.1016\/j.ogc.2021.02.007_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1447-0756.2012.02012.x","article-title":"Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction","volume":"39","author":"Yamamoto","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Res"},{"issue":"4","key":"10.1016\/j.ogc.2021.02.007_bib25","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.05.010","article-title":"Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (replaces clinical guideline number 3, April 2012)","volume":"223","author":"Society for Maternal-Fetal Medicine","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ogc.2021.02.007_bib26","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/pd.5054","article-title":"Antepartum management and obstetric outcomes among pregnancies with Down syndrome from diagnosis to delivery","volume":"37","author":"Guseh","year":"2017","journal-title":"Prenat Diagn"},{"issue":"Suppl","key":"10.1016\/j.ogc.2021.02.007_bib27","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA senior award lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?","volume":"35","author":"Redman","year":"2014","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.ogc.2021.02.007_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens"},{"issue":"4","key":"10.1016\/j.ogc.2021.02.007_bib29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1471-0528.2007.01277.x","article-title":"The association between customised small for gestational age infants and pre-eclampsia or gestational hypertension varies with gestation at delivery","volume":"114","author":"Groom","year":"2007","journal-title":"BJOG"},{"issue":"2S","key":"10.1016\/j.ogc.2021.02.007_bib30","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","volume":"218","author":"Groom","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2021.02.007_bib31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1471-0528.2010.02879.x","article-title":"Sildenafil citrate therapy for severe early-onset intrauterine growth restriction","volume":"118","author":"von Dadelszen","year":"2011","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.ogc.2021.02.007_bib32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.117.09690","article-title":"Sildenafil during pregnancy: a preclinical meta-analysis on fetal growth and maternal blood pressure","volume":"70","author":"Paauw","year":"2017","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ogc.2021.02.007_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2352-4642(17)30173-6","article-title":"Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial","volume":"2","author":"Sharp","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"8","key":"10.1016\/j.ogc.2021.02.007_bib34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/1471-0528.15658","article-title":"STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction","volume":"126","author":"Groom","year":"2019","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.ogc.2021.02.007_bib35","doi-asserted-by":"crossref","first-page":"e205323","DOI":"10.1001\/jamanetworkopen.2020.5323","article-title":"Maternal sildenafil vs placebo in pregnant women with severe early-onset fetal growth restriction: a randomized clinical trial","volume":"3","author":"Pels","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ogc.2021.02.007_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12884-016-1009-6","article-title":"Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: a meta-analysis","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"issue":"9","key":"10.1016\/j.ogc.2021.02.007_bib37","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3390\/nu12092535","article-title":"Prenatal amino acid supplementation to improve fetal growth: a systematic review and meta-analysis","volume":"12","author":"Terstappen","year":"2020","journal-title":"Nutrients"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2021.02.007_bib38","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.placenta.2017.09.011","article-title":"Maternal uterine artery VEGF gene therapy for treatment of intrauterine growth restriction","volume":"59","author":"David","year":"2017","journal-title":"Placenta"},{"issue":"9","key":"10.1016\/j.ogc.2021.02.007_bib39","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/1471-0528.15590","article-title":"Achieving orphan designation for placental insufficiency: annual incidence estimations in Europe","volume":"126","author":"Spencer","year":"2019","journal-title":"BJOG"},{"issue":"1\u20132","key":"10.1016\/j.ogc.2021.02.007_bib40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejogrb.2005.11.011","article-title":"Maternal and perinatal outcome of preeclampsia with an onset before 24\u00a0weeks' gestation. Audit in a tertiary referral center","volume":"128","author":"Gaugler-Senden","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ogc.2021.02.007_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/uog.20354","article-title":"Comparative analysis of 2-year outcomes in GRIT and TRUFFLE trials","volume":"55","author":"Ganzevoort","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9983","key":"10.1016\/j.ogc.2021.02.007_bib42","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(14)62049-3","article-title":"2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial","volume":"385","author":"Lees","year":"2015","journal-title":"Lancet"},{"issue":"2S","key":"10.1016\/j.ogc.2021.02.007_bib43","doi-asserted-by":"crossref","first-page":"S855","DOI":"10.1016\/j.ajog.2017.12.004","article-title":"Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy","volume":"218","author":"McCowan","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"8938","key":"10.1016\/j.ogc.2021.02.007_bib44","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(94)90457-X","article-title":"Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery","volume":"344","author":"Karsdorp","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2021.02.007_bib45","article-title":"Infant outcome after active management of early-onset fetal growth restriction with absent or reverse umbilical artery blood flow","author":"Morsing","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2021.02.007_bib46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1471-0528.1985.tb01103.x","article-title":"Improvements in the registration and analysis of fetal heart rate records at the bedside","volume":"92","author":"Dawes","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.ogc.2021.02.007_bib47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1515\/jpm-2018-0412","article-title":"Computerized fetal cardiotocography analysis in early preterm fetal growth restriction - a quantitative comparison of two applications","volume":"47","author":"Wolf","year":"2019","journal-title":"J\u00a0Perinat Med"},{"issue":"3","key":"10.1016\/j.ogc.2021.02.007_bib48","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0002-9378(91)90277-X","article-title":"Short-term variation in abnormal antenatal fetal heart rate records","volume":"165","author":"Street","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2021.02.007_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejogrb.2019.01.005","article-title":"The prognostic accuracy of short term variation of fetal heart rate in early-onset fetal growth restriction: a systematic review","volume":"234","author":"Pels","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"September","key":"10.1016\/j.ogc.2021.02.007_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/uog.18815","article-title":"Severe fetal growth restriction at 26\u201332\u00a0weeks: key messages from the TRUFFLE study","volume":"50","author":"Bilardo","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2021.02.007_bib51","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/uog.17433","article-title":"How to monitor pregnancies complicated by fetal growth restriction and delivery before 32\u00a0weeks: post-hoc analysis of TRUFFLE study","volume":"49","author":"Ganzevoort","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2021.02.007_bib52","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/uog.4101","article-title":"Computerized fetal heart rate analysis, Doppler ultrasound and biophysical profile score in the prediction of acid-base status of growth-restricted fetuses","volume":"30","author":"Turan","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2021.02.007_bib53","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/uog.14644","article-title":"Human fetal growth is constrained below optimal for perinatal survival","volume":"45","author":"Vasak","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.ogc.2021.02.007_bib54","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/AOG.0000000000000388","article-title":"Birth weight percentile and the risk of term perinatal death","volume":"124","author":"Moraitis","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2021.02.007_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.siny.2018.09.001","article-title":"Epidemiology of late preterm and early term births - an international perspective","volume":"24","author":"Delnord","year":"2019","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ogc.2021.02.007_bib56","doi-asserted-by":"crossref","first-page":"c7087","DOI":"10.1136\/bmj.c7087","article-title":"Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT)","volume":"341","author":"Boers","year":"2010","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ogc.2021.02.007_bib57","doi-asserted-by":"crossref","first-page":"406.e1-7","DOI":"10.1016\/j.ajog.2012.02.003","article-title":"Effects on (neuro)developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intrauterine growth-restricted infants: long-term outcomes of the DIGITAT trial","volume":"206","author":"van Wyk","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2021.02.007_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajog.2018.10.007","article-title":"Point: fetal growth and risk assessment: is there an impasse?","volume":"220","author":"Ganzevoort","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2021.02.007_bib59","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bpobgyn.2016.10.006","article-title":"An integrated approach to fetal growth restriction","volume":"38","author":"Figueras","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.ogc.2021.02.007_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejogrb.2010.04.017","article-title":"Systematic review and meta-analysis of the test accuracy of ductus venosus Doppler to predict compromise of fetal\/neonatal wellbeing in high risk pregnancies with placental insufficiency","volume":"152","author":"Morris","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ogc.2021.02.007_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.16375","article-title":"Cerebroplacental ratio in predicting adverse perinatal outcome: a meta-analysis of individual participant data","author":"Vollgraff Heidweiller-Schreurs","year":"2020","journal-title":"BJOG"},{"issue":"7","key":"10.1016\/j.ogc.2021.02.007_bib62","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/pd.4403","article-title":"Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation","volume":"34","author":"Bujold","year":"2014","journal-title":"Prenat Diagn"},{"issue":"7","key":"10.1016\/j.ogc.2021.02.007_bib63","doi-asserted-by":"crossref","first-page":"e029467","DOI":"10.1136\/bmjopen-2019-029467","article-title":"Pharmacological interventions for the prevention of fetal growth restriction: protocol for a systematic review and network meta-analysis","volume":"9","author":"Bettiol","year":"2019","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.ogc.2021.02.007_bib64","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ogc.2021.02.007_bib65","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ogc.2021.02.007_bib66","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","author":"Roberts","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"9321","key":"10.1016\/j.ogc.2021.02.007_bib67","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"Altman","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ogc.2021.02.007_bib68","article-title":"Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus","author":"Doyle","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.ogc.2021.02.007_bib69","doi-asserted-by":"crossref","first-page":"e1002398","DOI":"10.1371\/journal.pmed.1002398","article-title":"Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: an individual participant data meta-analysis","volume":"14","author":"Crowther","year":"2017","journal-title":"PLoS Med"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985452100019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985452100019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:19:41Z","timestamp":1760177981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985452100019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S088985452100019X"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2021.02.007","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation and Management of Suspected Fetal Growth Restriction","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2021.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}